Findings from the present study showed that tumors exhibiting higher levels of expression in MCM2, a marker of proliferation, and gelsolin, a marker of motility, conferred a higher risk of death in NSCLC. The gene discussed is MCM2; the disease is non-small cell lung carcinoma.